These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 23365201)

  • 1. The role of miR-18b in MDM2-p53 pathway signaling and melanoma progression.
    Dar AA; Majid S; Rittsteuer C; de Semir D; Bezrookove V; Tong S; Nosrati M; Sagebiel R; Miller JR; Kashani-Sabet M
    J Natl Cancer Inst; 2013 Mar; 105(6):433-42. PubMed ID: 23365201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long Noncoding RNA PVT1 Silencing Prevents the Development of Uveal Melanoma by Impairing MicroRNA-17-3p-Dependent MDM2 Upregulation.
    Wu S; Chen H; Han N; Zhang C; Yan H
    Invest Ophthalmol Vis Sci; 2019 Nov; 60(14):4904-4914. PubMed ID: 31770435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The oncoprotein HBXIP promotes human breast cancer growth through down-regulating p53 via miR-18b/MDM2 and pAKT/MDM2 pathways.
    Li H; Wang Z; Jiang M; Fang RP; Shi H; Shen Y; Cai XL; Liu Q; Ye K; Fan SJ; Zhang WY; Ye LH
    Acta Pharmacol Sin; 2018 Nov; 39(11):1787-1796. PubMed ID: 30181579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-340 inhibits prostate cancer cell proliferation and metastasis by targeting the MDM2-p53 pathway.
    Huang K; Tang Y; He L; Dai Y
    Oncol Rep; 2016 Feb; 35(2):887-95. PubMed ID: 26718483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of miR-18b/MDM2/p53 circuitry in melanoma progression.
    Jazirehi AR; Torres-Collado AX; Nazarian R
    Epigenomics; 2013 Jun; 5(3):254. PubMed ID: 24303553
    [No Abstract]   [Full Text] [Related]  

  • 6. Antitumor activity of miR-1280 in melanoma by regulation of Src.
    Sun V; Zhou WB; Nosrati M; Majid S; Thummala S; de Semir D; Bezrookove V; de Feraudy S; Chun L; Schadendorf D; Debs R; Kashani-Sabet M; Dar AA
    Mol Ther; 2015 Jan; 23(1):71-8. PubMed ID: 25195599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. microRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis.
    Zhang C; Liu J; Tan C; Yue X; Zhao Y; Peng J; Wang X; Laddha SV; Chan CS; Zheng S; Hu W; Feng Z
    Oncotarget; 2016 Feb; 7(8):8783-96. PubMed ID: 26840028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unbalancing p53/Mdm2/IGF-1R axis by Mdm2 activation restrains the IGF-1-dependent invasive phenotype of skin melanoma.
    Worrall C; Suleymanova N; Crudden C; Trocoli Drakensjö I; Candrea E; Nedelcu D; Takahashi SI; Girnita L; Girnita A
    Oncogene; 2017 Jun; 36(23):3274-3286. PubMed ID: 28092675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interaction.
    Fortunato O; Boeri M; Moro M; Verri C; Mensah M; Conte D; Caleca L; Roz L; Pastorino U; Sozzi G
    Cell Death Dis; 2014 Dec; 5(12):e1564. PubMed ID: 25501825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting negative regulation of p53 by MDM2 and WIP1 as a therapeutic strategy in cutaneous melanoma.
    Wu CE; Esfandiari A; Ho YH; Wang N; Mahdi AK; Aptullahoglu E; Lovat P; Lunec J
    Br J Cancer; 2018 Feb; 118(4):495-508. PubMed ID: 29235570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53/mdm2 feedback loop sustains miR-221 expression and dictates the response to anticancer treatments in hepatocellular carcinoma.
    Fornari F; Milazzo M; Galassi M; Callegari E; Veronese A; Miyaaki H; Sabbioni S; Mantovani V; Marasco E; Chieco P; Negrini M; Bolondi L; Gramantieri L
    Mol Cancer Res; 2014 Feb; 12(2):203-16. PubMed ID: 24324033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LINC00657/miR-26a-5p/CKS2 ceRNA network promotes the growth of esophageal cancer cells via the MDM2/p53/Bcl2/Bax pathway.
    Zhang XM; Wang J; Liu ZL; Liu H; Cheng YF; Wang T
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32426838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CircFSCN1 induces tumor progression and triggers epithelial-mesenchymal transition in bladder cancer through augmentation of MDM2-mediated p53 silencing.
    Deng W; Chen R; Xiong S; Nie J; Yang H; Jiang M; Hu B; Liu X; Fu B
    Cell Signal; 2024 Feb; 114():110982. PubMed ID: 37981069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-22 targets FMNL2 to inhibit melanoma progression via the regulation of the Wnt/β-catenin signaling pathway and epithelial-mesenchymal transition.
    Shi L; Huo JW; Chen SS; Xue JX; Gao WY; Li XY; Song YH; Xu HT; Zhu XW; Chen K
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5332-5342. PubMed ID: 31298385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-638 promotes melanoma metastasis and protects melanoma cells from apoptosis and autophagy.
    Bhattacharya A; Schmitz U; Raatz Y; Schönherr M; Kottek T; Schauer M; Franz S; Saalbach A; Anderegg U; Wolkenhauer O; Schadendorf D; Simon JC; Magin T; Vera J; Kunz M
    Oncotarget; 2015 Feb; 6(5):2966-80. PubMed ID: 25650662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-605 joins p53 network to form a p53:miR-605:Mdm2 positive feedback loop in response to stress.
    Xiao J; Lin H; Luo X; Luo X; Wang Z
    EMBO J; 2011 Feb; 30(3):524-32. PubMed ID: 21217645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-149*, a p53-responsive microRNA, functions as an oncogenic regulator in human melanoma.
    Jin L; Hu WL; Jiang CC; Wang JX; Han CC; Chu P; Zhang LJ; Thorne RF; Wilmott J; Scolyer RA; Hersey P; Zhang XD; Wu M
    Proc Natl Acad Sci U S A; 2011 Sep; 108(38):15840-5. PubMed ID: 21896753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor suppressing role of serum-derived exosomal microRNA-15a in osteosarcoma cells through the GATA binding protein 2/murine double minute 2 axis and the p53 signaling pathway.
    Wu C; Li Z; Feng G; Wang L; Xie J; Jin Y; Wang L; Liu S
    Bioengineered; 2021 Dec; 12(1):8378-8395. PubMed ID: 34592889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E2F1-dependent oncogenic addiction of melanoma cells to MDM2.
    Verhaegen M; Checinska A; Riblett MB; Wang S; Soengas MS
    Oncogene; 2012 Feb; 31(7):828-41. PubMed ID: 21743494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of microRNA-136 on melanoma cell proliferation, apoptosis, and epithelial-mesenchymal transition by targetting PMEL through the Wnt signaling pathway.
    Wang JJ; Li ZF; Li XJ; Han Z; Zhang L; Liu ZJ
    Biosci Rep; 2017 Oct; 37(5):. PubMed ID: 28724603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.